English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/202425
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Safety Assessment of Bacteroides Uniformis CECT 7771, a Symbiont of the Gut Microbiota in Infants

AuthorsGómez del Pulgar, Eva M. ; Benítez-Páez, Alfonso ; Sanz, Yolanda
KeywordsSafety
Probiotics
Bacteroides uniformis
Inflammation
Liver
Obesity
Metabolic function
Issue Date2020
PublisherMultidisciplinary Digital Publishing Institute
CitationNutrients 12(2): 551 (2020)
AbstractThe formulation of next-generation probiotics requires competent preclinical studies to show their efficacy and safety status. This study aims to confirm the safety of the prolonged oral use of Bacteroides uniformis CECT 7771, a strain that protected against metabolic disorders and obesity in preclinical trials, in a sub-chronic 90 day trial in animals. The safety assessment was conducted in male and female Wistar rats (n = 50) administered increasing doses (108 CFU/day, 109 CFU/day, or 1010 CFU/day) of B. uniformis CECT 7771, 1010 CFU/day of B. longum ATCC 15707T, which complies with the qualifying presumption of safety (QPS) status of the EU, or vehicle (placebo), as the control. Pancreatic, liver, and kidney functions and cytokine concentrations were analyzed. Bacterial translocation to peripheral tissues was evaluated, and colon integrity was investigated histologically. No adverse metabolic or tissue integrity alterations were associated with treatments; however, alanine aminotransferase levels and the ratio of anti-inflammatory to pro-inflammatory cytokines in serum indicated a potentially beneficial role of B. uniformis CECT 7771 at specific doses. Additionally, the microbial community structure was modified by the interventions, and potentially beneficial gut bacteria were increased. The results indicated that the oral consumption of B. uniformis CECT 7771 during a sub-chronic 90 day study in rats did not raise safety concerns.
Description© 2020 by the authors.
Publisher version (URL)https://doi.org/10.3390/nu12020551
URIhttp://hdl.handle.net/10261/202425
DOI10.3390/nu12020551
E-ISSN2072-6643
Appears in Collections:(IATA) Artículos
Files in This Item:
File Description SizeFormat 
Safety_Gomez_Art2020.pdf1,5 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.